Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIP1502 PK and Safety in Healthy Males
NCT04018378Phase 1Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of HIP1502 in nicotine dependence, sponsored by Korea University Anam Hospital. Primary endpoint: Area Under the Curve. Started Jan 2017; status: completed.
02
Drugs
HIP1502
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04018378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018378.